arrow
S

Selçuk Erdem

Istanbul University
H指数:20
被引数:1,356

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide in metastatic castration-resistant prostate cancer: a single-center retrospective study

[177Lu]Lu-PSMA-617放射性配体疗法联合或不联合恩扎卢胺治疗转移性去势抵抗性前列腺癌的疗效:一项单中心回顾性研究

2026-08-240
PRE
What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group

欧洲泌尿外科学会(EAU)青年学术泌尿外科医生(YAU)肾癌工作组关于Von Hippel-Lindau综合征患者肾癌管理建议:泌尿科医生需要了解什么?

2026-06-290
PRE
Renal epithelioid angiomyolipoma: A multi-institutional, international cohort study with emphasis on clinicopathologic prognostic indicators

肾上皮样血管平滑肌脂肪瘤:一项多中心、国际队列研究,重点在于临床病理预后指标

2026-01-010
PRE
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
2024-05-016
OAAI
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice
2024-04-016
OAAI
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy
2024-02-0111
OA